EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Urinary Antimony as a Biomarker for Differentiating Heroin and Brown Mixture Use

Shu-Mei Tsai, Yu-Han Hsiao, Yan-Zin Chang, Sai-Wai Ho

Journal of Food and Drug Analysis · 03.08.2026 · 34 (3)

DOI: 10.38212/2224-6614.3603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food and Drug Analysis, online erschienen am 03.08.2026. Verfasst von Shu-Mei Tsai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicine of Chung Shan Medical University, Taiwan. Hauptthemen laut MEDLINE: Heroin, Antimony, Substance Abuse Detection, Heroin Dependence. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heroin is classified as a Schedule I controlled substance with severe legal consequences for its use, whereas liquid Brown Mixture (BM) is a legally available and commonly prescribed cough remedy in Taiwan. However, numerous cases of BM ingestion have been misinterpreted as heroin use because BM contains opium tincture, leading to similar urine test results. Owing to the rapid metabolism of heroin, detection of the parent drug and its primary metabolite, 6-acetylmorphine, in urine is difficult; thus, interpretation often relies on morphine concentration and the morphine-to-codeine (M/C) ratio, which can be inconclusive. In our BM analysis, the M/C ratio was 3.3 ± 0.4, and among 5,094 morphine-positive urine samples, 279 (5.5%) had M/C ratios between 2 and 4, suggesting that a substantial number of individuals could be misidentified. Given the lack of reliable urinary biomarkers to distinguish BM from heroin use, this study aimed to identify BM-specific indicators. BM contains antimony (Sb) potassium tartrate, an emetic agent absent in heroin formulations. Although urinary Sb levels are low, they can be quantified using highly sensitive inductively coupled plasma mass spectrometry (ICP–MS). A pharmacokinetic study involving single and multiple BM doses revealed that urinary Sb increased from ≤ 0.11 ng/mL pre-dose to 0.4 – 98.9 ng/mL post-dose. Morphine and codeine were determined using gas chromatography–mass spectrometry (GC–MS), and M/C ratios ranged from 2.0 to 14.9, showing a secondary rise at later stages. These findings suggest that urinary Sb may serve as a useful supplementary biomarker for BM ingestion, thereby enhancing the accuracy of forensic toxicological interpretation and reducing false identification of heroin use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeroinAntimonySubstance Abuse DetectionHeroin DependenceHumansBiomarkersCodeineMorphine DerivativesTaiwanMorphine

Substanzen

BiomarkersHeroinAntimonyCodeineMorphine DerivativesMorphine

Autor:innen und Institutionen

  • Institute of Medicine of Chung Shan Medical University, Taiwan.
  • Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management, Taiwan.
  • Department of Nursing, Chung Shan Medical University Hospital, Taiwan.
  • Drug Testing Center, Department of Clinical Laboratory, Chung Shan Medical University Hospital, Taiwan.
  • Department of Emergency Medicine, Chung Shan Medical University Hospital, Taiwan.

Zitieren

APA

Tsai, S. M., Hsiao, Y. H., Chang, Y. Z., & Ho, S. W. (2026). Urinary Antimony as a Biomarker for Differentiating Heroin and Brown Mixture Use. Journal of Food and Drug Analysis, 34(3). https://doi.org/10.38212/2224-6614.3603

Vancouver

Tsai SM, Hsiao YH, Chang YZ, Ho SW. Urinary Antimony as a Biomarker for Differentiating Heroin and Brown Mixture Use. Journal of Food and Drug Analysis. 2026;34(3). doi:10.38212/2224-6614.3603

BibTeX
@article{Tsai2026,
  author = {Tsai, Shu-Mei and Hsiao, Yu-Han and Chang, Yan-Zin and Ho, Sai-Wai},
  title = {Urinary Antimony as a Biomarker for Differentiating Heroin and Brown Mixture Use},
  journal = {Journal of Food and Drug Analysis},
  year = {2026},
  volume = {34},
  number = {3},
  doi = {10.38212/2224-6614.3603}
}
Kostenlos starten →